These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 20594986

  • 1. Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study.
    Gligorov J, Bastit L, Gervais H, Henni M, Kahila W, Lepille D, Luporsi E, Sasso G, Varette C, Azria D, Candidoscope Study Group.
    Int J Radiat Oncol Biol Phys; 2011 Jun 01; 80(2):532-9. PubMed ID: 20594986
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial.
    Studena V, Sycova Z, Helpianska L, Sorkovska D, Pichna P, Lacka J, Hlavacova E, Oravcova E, Krcmery V, Studena M.
    J Chemother; 1995 Nov 01; 7 Suppl 4():204-5. PubMed ID: 8904157
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Miconazole (Oravig) for oropharyngeal candidiasis.
    Med Lett Drugs Ther; 2010 Nov 29; 52(1352):95-6. PubMed ID: 21116234
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
    Horn CA, Washburn RG, Givner LB, Peacock JE, Pegram PS.
    AIDS; 1995 May 29; 9(5):533-4. PubMed ID: 7639986
    [No Abstract] [Full Text] [Related]

  • 10. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
    Finlay PM, Richardson MD, Robertson AG.
    Br J Oral Maxillofac Surg; 1996 Feb 29; 34(1):23-5. PubMed ID: 8645677
    [Abstract] [Full Text] [Related]

  • 11. [Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
    Laguna F, Valencia E, Polo R, Moreno V, González-Lahoz JM.
    Rev Clin Esp; 1996 Dec 29; 196(12):878-9. PubMed ID: 9132869
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Candidiasis: pathogenesis, clinical characteristics, and treatment.
    Appleton SS.
    J Calif Dent Assoc; 2000 Dec 29; 28(12):942-8. PubMed ID: 11323949
    [Abstract] [Full Text] [Related]

  • 14. Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.
    Darouiche RO.
    Clin Infect Dis; 1998 Feb 29; 26(2):259-72; quiz 273-4. PubMed ID: 9502438
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oropharyngeal candidiasis treated with a troche form of clotrimazole.
    Yap BS, Bodey GP.
    Arch Intern Med; 1979 Jun 29; 139(6):656-7. PubMed ID: 375858
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone.
    Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S.
    Ann Allergy Asthma Immunol; 2003 Jun 29; 90(6):646-51. PubMed ID: 12839324
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.